MAFLD is associated with lower bone mineral density in patients with type 2 diabetes: an exploratory cross-sectional analysis of a potential indirect association with HOMA-IR - Scorecard - MDSpire
Advertisement
MAFLD is associated with lower bone mineral density in patients with type 2 diabetes: an exploratory cross-sectional analysis of a potential indirect association with HOMA-IR
Clinical Scorecard: The Relationship Between MAFLD and Reduced Bone Mineral Density in Type 2 Diabetes Patients: An Exploratory Cross-Sectional Study Examining the Role of HOMA-IR as a Potential Mediator
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Care Setting
Retrospective cross-sectional study in a hospital setting
Key Highlights
Insulin resistance (HOMA-IR) accounts for a small indirect effect on BMD (β = -0.070, 95% CI: -0.142 to -0.015).
Guideline-Based Recommendations
Diagnosis
Management
Consider pharmacological interventions for osteoporosis in high-risk patients.
Monitoring & Follow-up
Regular BMD assessments for T2DM patients with MAFLD.
Risks
Patient & Prescribing Data
169 patients with T2DM, including 108 men and 61 women.
Study suggests a need for monitoring bone health in T2DM patients with MAFLD.
Clinical Best Practices
Encourage lifestyle modifications to improve bone health.
National survey findings suggest many US adults report making health decisions based on social media despite widespread concerns about the accuracy of health information shared to the platforms.
Patients with preoperative vitamin D deficiency had higher postoperative pain scores and opioid use after mastectomy, including more than triple the odds of moderate to severe pain within 24 hours of surgery.
